Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Azn crawled time : 20:00 save search
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
| Email alert
Add to watchlist
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
| Email alert
Add to watchlist
DERM | $3.54 -8.29% -9.04% 190K
|
| Email alert
Add to watchlist
MBIO | $0.3819 -0.55% -1.05% 200K
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
| Email alert
Add to watchlist
CKPT | $1.595 -4.49% -4.7% 470K
|
Health Technology
| Email alert
Add to watchlist
biotech financial results
Global Orphan Drugs Market Research Report 2023: Market to Reach $415.2 Billion by the End of 2028 - Premium Pricing of Orphan Drugs and Increasing Collaborations/Licensing Agreements Bolsters Growth
Published: 2024-01-17 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.1%
H: 0.76%
C: 0.76%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: -2.34%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -0.6%
H: 0.34%
C: 0.34%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.78%
H: 0.59%
C: 0.57%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.54%
H: 1.55%
C: 1.33%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.1%
H: 1.63%
C: 1.59%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.51%
H: 1.33%
C: 0.93%
report reach research global growth market
Valo Health Announces Changes to its Board of Directors and Leadership Team
Published: 2024-01-16 (Crawled : 20:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.03%
H: 0.75%
C: 0.75%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
NTLA | $21.3 -0.93% -0.94% 1.1M
|
Health Technology
|
| O: -2.62%
H: 2.9%
C: -1.23%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -1.81%
H: 0.63%
C: 0.3%
health
ENHERTU® Demonstrated Clinically Meaningful Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial
Published: 2023-10-23 (Crawled : 20:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -1.57%
H: 1.06%
C: 0.36%
enhertu her2 tumors trial phase 2
Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-08-14 (Crawled : 20:00) - globenewswire.com
DERM | $3.54 -8.29% -9.04% 190K
|
|
| O: -2.75%
H: 4.01%
C: -0.47%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -1.75%
H: 0.0%
C: -2.23%
MBIO | $0.3819 -0.55% -1.05% 200K
|
Health Technology
|
| O: 0.0%
H: 0.07%
C: -5.71%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: -8.92%
H: 0.0%
C: 0.0%
CKPT | $1.595 -4.49% -4.7% 470K
|
Health Technology
|
| O: -0.96%
H: 2.42%
C: -2.42%
ATXI | $0.1311 -2.96% -3.05% 290K
|
Health Technology
|
| O: -2.37%
H: 4.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -1.27%
H: 0.26%
C: -0.61%
biotech financial results
Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-05-15 (Crawled : 20:00) - globenewswire.com
DERM | $3.54 -8.29% -9.04% 190K
|
|
| O: 2.41%
H: 8.42%
C: 1.01%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
MBIO | $0.3819 -0.55% -1.05% 200K
|
Health Technology
|
| O: 0.0%
H: 1.24%
C: -0.23%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 4.67%
H: 1.34%
C: -10.55%
CKPT | $1.595 -4.49% -4.7% 470K
|
Health Technology
|
| O: 1.41%
H: 2.79%
C: -2.79%
ATXI | $0.1311 -2.96% -3.05% 290K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.44%
H: 0.44%
C: -0.05%
biotech financial results
Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50
|
n/a
|
| O: -0.86%
H: 0.33%
C: 0.33%
CSLLY | $87.96 3.3% 45K
|
n/a
|
| O: -0.02%
H: 0.54%
C: -1.7%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -2.57%
H: 1.62%
C: 1.62%
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: 0.41%
H: 0.39%
C: -2.14%
TEVA | $12.78 -3.03% -0.24% 9M
|
Health Technology
|
| O: -1.21%
H: 0.43%
C: -3.58%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.83%
H: 0.06%
C: -1.2%
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.76%
H: 1.91%
C: 1.26%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.32%
H: 0.17%
C: -1.53%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.01%
H: 0.42%
C: -2.62%
CTLT | $55.8 -0.29% 0.0% 1M
|
Health Technology
|
| O: 0.11%
H: 0.53%
C: -5.05%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.41%
H: 0.04%
C: -1.71%
ALB | News | $111.8 -2.26% 0.63% 2.2M
|
Process Industries
|
| O: -0.95%
H: 1.02%
C: -2.19%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.19%
H: 0.06%
C: -1.7%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: -1.25%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: -2.26%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.9%
H: 0.28%
C: -1.3%
global report market
Resilience to Establish a Biomanufacturing Partnership with AstraZeneca and Purchase AstraZeneca’s Manufacturing Site in West Chester, Ohio
Published: 2022-11-29 (Crawled : 20:00) - biospace.com/
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -1.93%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.21%
H: 0.16%
C: -0.41%
partnership
Pharmaceutical Drug Delivery Global Market Report 2022: Adoption of Nano-Based Drug Delivery Systems Presents Opportunities
Published: 2022-10-11 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.93%
H: 0.0%
C: -0.17%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -0.15%
H: 0.61%
C: 0.09%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.07%
H: 0.48%
C: -0.66%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.0%
H: 0.67%
C: -0.2%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.07%
H: 1.92%
C: -0.86%
BSX | $67.42 -0.8% -0.53% 5.9M
|
Health Technology
|
| O: 0.38%
H: 0.35%
C: -0.28%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.09%
H: 1.0%
C: -1.17%
MMM | $91.48 0.57% 0.0% 3M
|
Producer Manufacturing
|
| O: -0.25%
H: 1.04%
C: 0.35%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.67%
H: 0.95%
C: 0.25%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.44%
H: 1.79%
C: 0.85%
drug global report market
Respiratory Drugs Market size to grow by USD 26.95 Bn at 5.96% CAGR during 2026, Discover Company Insights in Technavio
Published: 2022-09-19 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -6.97%
H: 7.7%
C: -0.76%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -0.34%
H: 6.64%
C: -0.06%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.96%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.82%
H: 0.07%
C: -0.61%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.71%
H: 0.2%
C: -0.23%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.59%
H: 0.47%
C: -0.04%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -1.25%
H: 0.23%
C: -0.47%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -1.16%
H: 0.56%
C: 0.14%
respiratory market
U.S. Gastroesophageal Reflux Disease Devices Market Report 2022-2027: Key Players AstraZeneca, Pfizer, Procter & Gamble & Others Driving 15.47% Growth
Published: 2022-07-29 (Crawled : 20:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
| Email alert
Add to watchlist
MDGS | $2.48 13.78% 12.11% 25K
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
| Email alert
Add to watchlist
disease report growth market
Global Pharmaceutical Drug Delivery Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-07-25 (Crawled : 20:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 3.39%
H: 0.42%
C: -1.6%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.96%
H: 0.47%
C: -0.08%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.17%
H: 0.48%
C: 0.17%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.62%
H: 1.09%
C: 0.23%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.37%
H: 1.66%
C: 0.6%
drug global market
Insights on the Biologics Global Market to 2027 - by Source, Product, Disease, Manufacturing and Region
Published: 2022-07-19 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 36.07%
H: 0.0%
C: -9.7%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -3.45%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -4.54%
H: 3.88%
C: 3.88%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.81%
H: 0.05%
C: -1.27%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.23%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -4.81%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -1.88%
H: 0.15%
C: -1.63%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.25%
H: 0.71%
C: -0.03%
global market
Global Smart Inhalers Market to 2027 - Size, Share & Industry Trends Analysis Report
Published: 2022-05-23 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -2.41%
H: 0.0%
C: -1.7%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -0.21%
H: 2.54%
C: 1.27%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
OPK | $1.235 -1.2% -1.21% 4.1M
|
Health Technology
|
| O: -1.94%
H: 2.14%
C: -0.33%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
report smart market
Global GLP-1 Receptor Agonist Market Research Report to 2027 - Featuring Novo Nordisk, PegBio and Sanofi Among Others
Published: 2022-04-26 (Crawled : 20:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 3.45%
H: 0.0%
C: -3.43%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.91%
H: 1.47%
C: 0.53%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 1.94%
H: 0.59%
C: -0.2%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.33%
H: 1.2%
C: -0.1%
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: -0.22%
H: 5.12%
C: -0.7%
research report sanofi market
Global Cancer Antibody Drug Conjugates Industry, 2022-2028 - A $25B+ Opportunity Assessment with Daiichi Sankyo, Roche, Gilead Sciences, ADC Therapeutics, AstraZenca, and Seagen Dominating
Published: 2022-03-01 (Crawled : 20:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.37%
H: 2.02%
C: 2.02%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
drug therapeutics cancer antibody
Global Breast Cancer Diagnostics Markets, 2015-2020, 2020-2025F, 2030F: Focus on Imaging, Biopsy, Genomic Tests, & Blood Tests
Published: 2021-09-13 (Crawled : 20:00) - prnewswire.com
DGX | $125.91 -0.84% -0.7% 870K
|
Health Services
|
| O: 0.6%
H: 0.68%
C: -0.01%
PHG | $19.98 -0.84% 0.0% 500K
|
Health Technology
|
| O: 0.73%
H: 0.13%
C: -0.4%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.58%
H: 0.5%
C: -0.24%
EXAS | $63.45 0.36% 0.36% 1.6M
|
Health Technology
|
| O: 0.57%
H: 0.22%
C: -3.18%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.67%
H: 0.25%
C: -0.67%
blood test genomic cancer breast cancer diagnostics imaging diagnostic
Global $191 Billion Orphan Drugs Markets to 2026: Therapeutic Applications in Rare and Orphan Diseases, Regulatory Framework, Patents, and Innovations
Published: 2021-08-05 (Crawled : 20:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.85%
H: 0.15%
C: -0.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -2.02%
H: 0.09%
C: -1.38%
disease drug patent application rare
Worldwide Pneumococcal Vaccine Industry to 2026 - Development of Protein-Based Combination Pneumococcal Vaccines Presents Opportunities
Published: 2021-06-16 (Crawled : 20:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.15%
H: 0.92%
C: 0.63%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.47%
H: 0.44%
C: 0.25%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.6%
H: 0.69%
C: 0.5%
vaccine pneumococcal
North America Preventive Vaccines Market: COVID-19 Impact and Growth Opportunity 2021-2026
Published: 2021-06-11 (Crawled : 20:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
| Email alert
Add to watchlist
covid vaccine growth covid-19
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.